The CBSE Class 12 Biology exam will be held on March 27, 2026. It is normal to feel excited or a little nervous. Biology is not just about memorising terms. You need to understand how things work, ...
CBSE Class 12 Biology Pre Board Sample Paper 2025-2026: The CBSE Class 12 Biology Pre-Board Exam 2026 will be conducted on 27 March 2026 (Friday). As the exam date approaches, students are preparing ...
ICSE, ISC Board Exams 2025 Live: Put the signature in the space provided on the top sheet of the main answer booklet. Do not scribble anywhere on the top sheet. ICSE, ISC Board Exams 2025 Live: Write ...
Students choose between creating a zine, writing a traditional research paper, or designing a game—each focused on a conservation-related topic of their choice. All project formats require research, ...
CBSE class 10, 12 exams to be conducted on March 3, 2026, rescheduled. Class 10 revised exams to be held on March 11, 2026 Class 12 revised exams to be held on 10 April 2026 The CBSE Board Exam 2026 ...
Hong Kong's biotech fundraising momentum is expected to extend into 2026, as licensing deals and strong post-initial public offering (IPO) trading last year persuaded investors that China's drug ...
A class action is a type of legal action where a representative individual or group of individuals can bring a claim on behalf of a larger group or class who share a common legal interest.
A class action is a type of legal action where a representative individual or group of individuals can bring a claim on behalf of a larger group or class who share a common legal interest.
The A.I. Center of Excellence is planned to be based in Bengaluru and focus on large scale data-engineering, development and ...
Hut 8 surges on the $7B Fluidstack Google-backed lease and River Bend expansion. Read the full analysis here of the HUT stock ...
This is an edition of The Atlantic Daily, a newsletter that guides you through the biggest stories of the day, helps you discover new ideas, and recommends the best in culture. Sign up for it here. A ...
Foresee Pharmaceuticals has sold a chunk of its clinical-stage pipeline in order to focus on the potential of its prostate cancer med Camcevi. In return for $10 million upfront, Foresee sold the ...